- Home
- NCI vs ACXP Comparison
NCI vs ACXP Comparison
Compare NCI & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCI
- ACXP
- Stock Information
- Founded
- NCI 1992
- ACXP 2017
- Country
- NCI Hong Kong
- ACXP United States
- Employees
- NCI N/A
- ACXP N/A
- Industry
- NCI
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- NCI
- ACXP Health Care
- Exchange
- NCI NYSE
- ACXP Nasdaq
- Market Cap
- NCI 11.0M
- ACXP 9.0M
- IPO Year
- NCI 2024
- ACXP 2021
- Fundamental
- Price
- NCI $0.39
- ACXP $0.46
- Analyst Decision
- NCI
- ACXP Strong Buy
- Analyst Count
- NCI 0
- ACXP 1
- Target Price
- NCI N/A
- ACXP $12.00
- AVG Volume (30 Days)
- NCI 436.7K
- ACXP 485.1K
- Earning Date
- NCI 12-19-2024
- ACXP 03-18-2025
- Dividend Yield
- NCI N/A
- ACXP N/A
- EPS Growth
- NCI N/A
- ACXP N/A
- EPS
- NCI 0.08
- ACXP N/A
- Revenue
- NCI $22,481,862.00
- ACXP N/A
- Revenue This Year
- NCI N/A
- ACXP N/A
- Revenue Next Year
- NCI N/A
- ACXP N/A
- P/E Ratio
- NCI $5.11
- ACXP N/A
- Revenue Growth
- NCI N/A
- ACXP N/A
- 52 Week Low
- NCI $0.35
- ACXP $0.43
- 52 Week High
- NCI $11.39
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- NCI N/A
- ACXP 30.25
- Support Level
- NCI N/A
- ACXP $0.43
- Resistance Level
- NCI N/A
- ACXP $0.47
- Average True Range (ATR)
- NCI 0.00
- ACXP 0.06
- MACD
- NCI 0.00
- ACXP -0.02
- Stochastic Oscillator
- NCI 0.00
- ACXP 6.47
About NCI NEO-CONCEPT INTL GRP HLDGS LTD
Neo-Concept International Group Holdings Ltd is a company whose a one-stop apparel solution services provider. It offers a full suite of services in the apparel supply chain, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management serving customers located in the European, and North American markets through Neo-Concept HK.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.